The Royal Pharmaceutical Society (RPS) is leading a new project to examine the causes of the growing challenge of medicines shortages and help tackle their impact on patients and pharmacy practice.
A new advisory group, convened by RPS and chaired by RPS Fellow Dr Bruce Warner, will meet later this month and bring together experts from primary and secondary care, patients, the pharmaceutical industry, suppliers, regulators, government and the NHS.
Read full press release
Source: The Royal Pharmaceutical Society, 13 March 2024